PRECISION BIOSCIENCES INC
DTILNext catalyst
No upcoming catalyst in our data
No upcoming FDA decision, filing or trial readout is on file for DTIL. That does not mean none is planned.
Get an email about DTIL's next catalysts
Track PRECISION BIOSCIENCES (DTIL) and we email you when an FDA date moves, 7 days and 1 day before the decision when the exact day is known, and when it is announced. Free account, no card.
0 upcoming, 3 past
No catalysts found.
Market Overview
Stock performance and key metrics
Precision BioSciences, Inc. is a publicly traded American clinical stage gene editing company headquartered in Durham, North Carolina. Founded in 2006, Precision is focused on developing both in vivo and ex vivo gene editing therapies using its proprietary "ARCUS" genome editing platform.
WebsiteNPC-1C/NEO-102
Metastatic Pancreatic Cancer
NEO-201 in combination with pembrolizumab
Non Small Cell Lung Cancer
PBGENE-DMD (IV)
Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD
| Drug Name | Phase | Indication | Designations | Patent |
|---|---|---|---|---|
NPC-1C/NEO-102 | Phase 2 | Metastatic Pancreatic Cancer | - | - |
NEO-201 in combination with pembrolizumab | Phase 2 | Non Small Cell Lung Cancer | - | - |
PBGENE-DMD (IV) | Phase 2 | Duchenne Muscular Dystrophy With Mutations Amenable to PBGENE-DMD | - | - |
Frequently asked questions
What is in PRECISION BIOSCIENCES INC's drug pipeline?β
CatalystAlert tracks 3 drug candidates in PRECISION BIOSCIENCES INC's (DTIL) pipeline across Phase 2. Its lead program is NEO-201 in combination with pembrolizumab (Phase 2). Each drug's phase, indication and upcoming catalysts are listed on this page.
When is PRECISION BIOSCIENCES INC's next FDA catalyst?β
CatalystAlert tracks every upcoming catalyst for PRECISION BIOSCIENCES INC (DTIL) β PDUFA decision dates, Phase 1/2/3 trial readouts, FDA advisory committee meetings and NDA/BLA filings β each confidence-rated as confirmed, estimated or AI-detected.
How do I track DTIL biotech catalysts?β
Add DTIL to your CatalystAlert watchlist for alerts ahead of each catalyst, and follow PRECISION BIOSCIENCES INC's live catalyst calendar, drug pipeline and clinical-trial timeline on this page β sourced from ClinicalTrials.gov, FDA and SEC filings.
